Our organisation has several programs working with people living with Blood Born Viruses in the Northern Territory.
As well as supporting people living with BBV we also concentrate on Harm Minimization through education and access to cheap resources.
NTAHC is the key Non-Government organisation working in the area of blood borne viruses, education and support in the Northern Territory. NTAHC operates on a holistic approach in accordance with the objects of the Ottawa Charter (1986), and guided by key National and Northern Territory policies and legislation.
The programs delivered by the organisation include:
• Care & Support
• Sex Worker Outreach Program
• Needle and Syringe Program
• Aboriginal Sexual Health
Services and activities include:
Care and Support services to people living with blood borne viruses and people at risk, providing support, counselling and referring clients onto other services as required.
Health promotion through the development of targeted health promotion materials, campaigns and resources as well as provision of information at health expo’s, schools and to the broader community at community events and festivals.
Education sessions delivered to community based organisations / prisons / detention centres / general community / businesses and health professionals to raise awareness and reduce Blood borne virus transmissions.
Peer Support Groups for people living with blood borne viruses.
The provision of free safe sex products.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close